https://www.selleckchem.com/pr....oducts/idasanutlin-r
5-52.5] vs. MRSA screen, 24.5h [IQR 20.6-40.3]; p=0.28). Of patients who were screened, 35 were negative and 2 were positive. Secondary outcomes were similar. Performing a MRSA nares screen in the ED for patients diagnosed with pneumonia, initiated on anti-MRSA antibiotics, and admitted to a general medicine floor did not decrease duration of anti-MRSA antibiotics. At this time, ED providers do not need to consider a MRSA nasal screen in the ED for patients being admitted to general medicine, although larger studies could be
Beğen
Yorum Yap
Paylaş
